Microbplex Inc.

Microbplex, Inc.

UEI
CLP4DJ9UWNK9
CAGE
6TAH1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Microbplex Inc.'s 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Novel diagnostics for early lyme disease Grant · R43AI134543 National Institute of Allergy and Infectious Diseases $596,428
Sbir phase II Contract · HHSD200201588233C CDC Pittsburgh $987,059
Sbir phase i topic OO6 Contract · HHSD2002014M60933P CDC Office of Acquisition Services $149,999
Lab supplies Contract · HHSD2002014M59239P CDC Office of Acquisition Services $139,200

Quick answers

What is Microbplex Inc.'s UEI?

Microbplex Inc.'s Unique Entity ID (UEI) in SAM.gov is CLP4DJ9UWNK9.

What is Microbplex Inc.'s CAGE code?

Microbplex Inc.'s CAGE code is 6TAH1.

What is Microbplex Inc.'s primary NAICS code?

Microbplex Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Microbplex Inc. registered in SAM.gov?

Microbplex Inc.'s SAM.gov registration expired on April 28, 2025.

What is Microbplex Inc.'s most recent federal award?

Microbplex Inc.'s most recent federal grant award is Novel diagnostics for early lyme disease (R43AI134543), from National Institute of Allergy and Infectious Diseases, on April 1, 2018.

On GovTribe

See Microbplex Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login